Literature DB >> 3976112

Gleason grading of prostate cancer: a predictor of survival.

P C Sogani, A Israel, P H Lieberman, M L Lesser, W F Whitmore.   

Abstract

The Gleason grading system was employed in the pathologic assessment of 82 patients with carcinoma of the prostate diagnosed between 1962-1965 and subsequently followed to death. The data suggest that the Gleason grade gives long-term prognostic information independent of stage with a direct correlation between increasing Gleason grade and cancer death rate index. Furthermore, the sum of clinical stage plus Gleason grade is a more significant prognostic factor than either stage or grade alone.

Entities:  

Mesh:

Year:  1985        PMID: 3976112     DOI: 10.1016/0090-4295(85)90316-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

1.  Intraobserver and interobserver reproducibility of WHO and Gleason histologic grading systems in prostatic adenocarcinomas.

Authors:  S O Ozdamar; S Sarikaya; L Yildiz; M K Atilla; B Kandemir; S Yildiz
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

2.  Clinical study on prognosis of metastatic prostate cancer based on extent of disease on pretreatment bone scintigraphy.

Authors:  H Fuse; I Mizuno; T Yokoyama; M Sakamoto; T Katayama
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer.

Authors:  William D Figg; Michael E Franks; David Venzon; Paul Duray; Michael C Cox; W Marston Linehan; W Van Bingham; James A Eastham; Eddie Reed; Oliver Sartor
Journal:  World J Urol       Date:  2004-12-08       Impact factor: 4.226

4.  The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study.

Authors:  India Anderson-Carter; Natasza Posielski; Jinn-Ing Liou; Tariq A Khemees; Tracy M Downs; E Jason Abel; David F Jarrard; Kyle A Richards
Journal:  Urol Oncol       Date:  2018-12-07       Impact factor: 3.498

5.  Nuclear grading versus Gleason grading in small samples containing prostate cancer: a tissue microarray study.

Authors:  Daniel Wittschieber; Jens Köllermann; Thorsten Schlomm; Guido Sauter; Andreas Erbersdobler
Journal:  Pathol Oncol Res       Date:  2010-04-23       Impact factor: 3.201

6.  Histologic grading of prostatic adenocarcinoma: intraobserver reproducibility of the Mostofi, Gleason and Böcking grading systems.

Authors:  M L Cintra; A Billis
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

7.  Long-term outcome following radical prostatectomy for Gleason 8-10 prostatic adenocarcinoma.

Authors:  Naveen Pokala; Jerry J Trulson; Majdee Islam
Journal:  World J Urol       Date:  2014-02-09       Impact factor: 4.226

8.  Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; Malcolm Mason; Chris Metcalfe; Peter Holding; Julia Wade; Sian Noble; Kirsty Garfield; Grace Young; Michael Davis; Tim J Peters; Emma L Turner; Richard M Martin; Jon Oxley; Mary Robinson; John Staffurth; Eleanor Walsh; Jane Blazeby; Richard Bryant; Prasad Bollina; James Catto; Andrew Doble; Alan Doherty; David Gillatt; Vincent Gnanapragasam; Owen Hughes; Roger Kockelbergh; Howard Kynaston; Alan Paul; Edgar Paez; Philip Powell; Stephen Prescott; Derek Rosario; Edward Rowe; David Neal
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

9.  Impact of a rectal and bladder preparation protocol on prostate cancer outcome in patients treated with external beam radiotherapy.

Authors:  A Maggio; D Gabriele; E Garibaldi; S Bresciani; E Delmastro; A Di Dia; A Miranti; M Poli; T Varetto; M Stasi; P Gabriele
Journal:  Strahlenther Onkol       Date:  2017-06-15       Impact factor: 3.621

10.  Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness.

Authors:  Ji Chen; Yong Zhao; Xin Li; Peng Sun; Muwen Wang; Ridong Wang; Xunbo Jin
Journal:  Radiol Oncol       Date:  2012-06-19       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.